Seizures Flashcards
Creasy, EB MFM
Brand name: Phenytoin
Dilantin
Brand name: Carbamazepine
Tegretol
Brand name: Valproic acid
Depakote
Brand name: Levetiracetam
Keppra
General therapeutic recommendations for treatment of epilepsy in pregnancy
Smallest effective dose, monotherapy preferable
Folate supplementation of 4 mg daily
History to document in the epileptic patient
Aura - present or absent
Seizure description by eyewitness, including duration
Postictal phase - description, duration
Exacerbating factors
Birth history, esp if seizure onset was neonatal or early childhood
History of febrile convulsions, CNS infections, or head trauma w/ LOC
Family history
Fetal complications of epilepsy
Fetal loss
Perinatal death
Congenital malformations (4-8%, or twice baseline risk)
Low birth weight
Prematurity
Developmental delay
Childhood epilepsy
Preconception counseling of the epileptic patient
There is a small risk of having a child with a malformation because of the sz disorder or the drugs used in its treatment. This risk is probably about double that for the nonepileptic patient (4-8%, compared with 2-3% for the general population), but there is still more than 90% chance that she will have a normal child.
Preconception folic acid (4 mg) may be considered to reduce the risk of major congenital malformations.
Preconception counseling: when can an anticonvulsant be stopped, and when should the patient attempt conception
Consider neuro consultation regarding tapering off AEDs if the patient has been seizure free for > 2 years and has a nl EEG. The patient should be observed for 6-12 months off AED before attempting conception.
Seizure freedom for at least __ months before pregnancy is associated with a high likelihood of remaining seizure-free during pregnancy
9 months
Risk of epilepsy in offspring
2-3%
Prenatal care of the epileptic patient
Folic acid 4 mg/day
Anatomic US at 11-13w to identify severe defects
AFP at 15-18w gestation for NTDs
Targeted US at 16-20w
Fetal echo at 22w
+/- growth US at 32w
Neonates should receive 1 mg IM Vit K at birth
Which anticonvulsants should have levels monitored during pregnancy?
Lamotrigine
Carbamazapine
Phenytoin
Levetiracetam
Oxcarbazepine
Anticonvulsants that interfere with oral contraceptives
Enzyme-inducing AEDS:
Phenytoin
Phenobarbital
Carbemazepine
Topiramate (>200 mg/day)
Primidone
Drugs that may interfere with absorption of anticonvulsants
Folic acid may lower plasma phenytoin level
Antacids
Antihistamines